Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

U.S. Markets are not yet open, but AZN is being traded in the pre-market session. Pre-Market quote »
28.96
Delayed Data
As of Apr 29
 -0.31 / -1.06%
Today’s Change
27.68
Today|||52-Week Range
35.34
-14.70%
Year-to-Date

Today’s Trading

Previous close29.27
Today’s open29.73
Day’s range28.88 - 29.76
Volume4,752,661
Average volume (3 months)4,444,327
Market cap$73.2B
Dividend yield4.83%
Data as of 04/29/2016

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-5.85%
Earnings growth (next 5 years)+1.66%
Revenue growth (last year)-5.11%
P/E ratio25.9
Price/Sales3.48
Price/Book3.96

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-4.62-4.28%
LLYEli Lilly and Co-0.93-1.22%
AGNAllergan-2.29-1.05%
ABTAbbott Laboratories-1.52-3.76%
Data as of 04/29/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.53
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts

Partner Offers

Search for Jobs